Preclinical toxicology of anticancer agents
- PMID: 404039
Preclinical toxicology of anticancer agents
Similar articles
-
Toxicology of anticancer drugs.Natl Cancer Inst Monogr. 1977 Mar;(45):49-55. Natl Cancer Inst Monogr. 1977. PMID: 412105 No abstract available.
-
The clinical toxicity of anticancer drugs and its prediction.Semin Oncol. 1977 Jun;4(2):147-63. Semin Oncol. 1977. PMID: 406677 Review. No abstract available.
-
Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.Cancer Chemother Rep 3. 1974 Sep;5(1):1-7. Cancer Chemother Rep 3. 1974. PMID: 4213305 No abstract available.
-
Preclinical toxicology of alpha-2'-deoxythioguanosine (NSC-71851).Cancer Chemother Rep 3. 1974 Sep;5(1):9-14. Cancer Chemother Rep 3. 1974. PMID: 4213304 No abstract available.
-
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.Cancer Treat Rep. 1986 Mar;70(3):383-9. Cancer Treat Rep. 1986. PMID: 3082512 Review.
Cited by
-
The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia.Ther Adv Hematol. 2023 Oct 17;14:20406207231205429. doi: 10.1177/20406207231205429. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37854355 Free PMC article. Review.
-
Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials.Oncologist. 2015 Jun;20(6):653-9. doi: 10.1634/theoncologist.2015-0008. Epub 2015 May 11. Oncologist. 2015. PMID: 25964306 Free PMC article.